Is more of a good thing still a good thing? PARP inhibitor retreatment in high-grade ovarian carcinoma

被引：0
|
作者：
McNeish, I. A. [1 ]
Monk, B. J. [2 ]
机构：
[1] Imperial Coll London, Ovarian Canc Act Res Ctr, Dept Surg & Canc, London, England
[2] Univ Arizona, HonorHlth Res Inst, Coll Med, Div Gynecol Oncol, Phoenix, AZ USA
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷 / 12期
关键词：
OLAPARIB MAINTENANCE THERAPY; DOUBLE-BLIND; OPEN-LABEL; CANCER; RUCAPARIB; PHASE-2; RESISTANCE; MULTICENTER; MUTATIONS;
D O I：
10.1016/j.annonc.2023.08.014
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1074 / 1076
页数：3
相关论文
共 50 条
  • [21] Architectural Patterns of Ovarian/Pelvic High-grade Serous Carcinoma
    Bromley, Amy B.
    Altman, Alon D.
    Chu, Pamela
    Nation, Jill G.
    Nelson, Gregg S.
    Ghatage, Praful
    Kalloger, Steve E.
    Han, Guangming
    Koebel, Martin
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2012, 31 (05) : 397 - 404
  • [22] Spatially resolved transcriptomics of high-grade serous ovarian carcinoma
    Stur, Elaine
    Corvigno, Sara
    Xu, Mingchu
    Chen, Ken
    Tan, Yukun
    Lee, Sanghoon
    Liu, Jinsong
    Ricco, Emily
    Kraushaar, Daniel
    Castro, Patricia
    Zhang, Jianhua
    Sood, Anil K.
    ISCIENCE, 2022, 25 (03)
  • [23] Consensus on Molecular Subtypes of High-Grade Serous Ovarian Carcinoma
    Chen, Gregory M.
    Kannan, Lavanya
    Geistlinger, Ludwig
    Kofia, Victor
    Safikhani, Zhaleh
    Gendoo, Deena M. A.
    Parmigiani, Giovanni
    Birrer, Michael
    Haibe-Kains, Benjamin
    Waldron, Levi
    CLINICAL CANCER RESEARCH, 2018, 24 (20) : 5037 - 5047
  • [24] Histone methyltransferases EHMT1 and EHMT2 (GLP/G9A) maintain PARP inhibitor resistance in high-grade serous ovarian carcinoma
    Zachary L. Watson
    Tomomi M. Yamamoto
    Alexandra McMellen
    Hyunmin Kim
    Connor J. Hughes
    Lindsay J. Wheeler
    Miriam D. Post
    Kian Behbakht
    Benjamin G. Bitler
    Clinical Epigenetics, 2019, 11
  • [25] Neoplastic cellularity is associated with clinical and molecular features of high-grade serous ovarian carcinoma
    Morse, Christopher B.
    Norquist, Barbara M.
    Harrell, Maria I.
    Agnew, Kathy J.
    Gray, Heidi J.
    Urban, Renata R.
    Garcia, Rochelle L.
    Goff, Barbara A.
    Swisher, Elizabeth M.
    GYNECOLOGIC ONCOLOGY, 2016, 143 (02) : 389 - 392
  • [26] Schlafen 11 Assessment in High-Grade Serous Ovarian Carcinoma Phenotypic and Histological Distribution
    Ferraioli, Domenico
    Penuela, Leonardo
    Garuti, Anna
    Carrozzi, Chiara
    Olivier, Timothee
    Spina, Bruno
    Salvi, Sandra
    Ferrero, Simone
    Tille, Jean-Christophe
    Labidi-Galy, Sana Intidhar
    Cirmena, Gabriella
    Ballestero, Alberto
    Chopin, Nicolas
    Beurrier, Frederic
    Treilleux, Isabelle
    Ray-Coquard, Isabelle
    Zoppoli, Gabriele
    Vellone, Valerio Gaetano
    ANALYTICAL AND QUANTITATIVE CYTOPATHOLOGY AND HISTOPATHOLOGY, 2018, 40 (05): : 222 - 230
  • [27] Biomarker Expression in Pelvic High-grade Serous Carcinoma: Comparison of Ovarian and Omental Sites
    Koebel, Martin
    Turbin, Dmitry
    Kalloger, Steve E.
    Gao, Dongxia
    Huntsman, David G.
    Gilks, C. Blake
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2011, 30 (04) : 366 - 371
  • [28] Genetic heterogeneity and evolutionary history of high-grade ovarian carcinoma and matched distant metastases
    Masoodi, Tariq
    Siraj, Sarah
    Siraj, Abdul K.
    Azam, Saud
    Qadri, Zeeshan
    Parvathareddy, Sandeep K.
    Tulbah, Asma
    Al-Dayel, Fouad
    AlHusaini, Hamed
    AlOmar, Osama
    Al-Badawi, Ismail A.
    Alkuraya, Fowzan S.
    Al-Kuraya, Khawla S.
    BRITISH JOURNAL OF CANCER, 2020, 122 (08) : 1219 - 1230
  • [29] Clonal evolution of high-grade serous ovarian carcinoma from primary to recurrent disease
    Castellarin, Mauro
    Milne, Katy
    Zeng, Thomas
    Tse, Kane
    Mayo, Michael
    Zhao, Yongjun
    Webb, John R.
    Watson, Peter H.
    Nelson, Brad H.
    Holt, Robert A.
    JOURNAL OF PATHOLOGY, 2013, 229 (04) : 515 - 524
  • [30] Impact of neoadjuvant chemotherapy on somatic mutation status in high-grade serous ovarian carcinoma
    Marchocki, Zibi
    Tone, Alicia
    Virtanen, Carl
    de Borja, Richard
    Clarke, Blaise
    Brown, Theodore
    May, Taymaa
    JOURNAL OF OVARIAN RESEARCH, 2022, 15 (01)
12345